Inflammation of seborrheic keratoses due to docetaxel treatment.
Chu
C Y
CY
Yang
C H
CH
Chiu
H C
HC
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D000077143:Docetaxel; D005260:Female; D006801:Humans; D007249:Inflammation / Q000139:chemically induced; D017492:Keratosis, Seborrheic / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel